NVAX about to break from an ascending triangleNVAX about to break from an descending triangle with good risk to reward ratio
NVV1 trade ideas
NVAX Round Up/ Rebound WaveNVAX is basing nicely above the moving averages and is showing a rounding up behavior, it has also posted several recent higher lows. This is showing strength in price and looks like 227 may be the first target.
Novavax possible head and shoulders?Right shoulder forming. Could be large breakout with multiple approvals in July!
NVAX on the daily, Could be looking at a pop upwardsUsing Wyckoff on the daily it looks like NVAX is setting up for a move to the upward direction. Play it how you how want and do your own DD, but I am may be looking at some credit spreads.
Are we close to observe a breakout on NVAX ?Novavax COVID-19 vaccine more than 90% effective in U.S trial according to Reuters. Despite positive news (which we do not trade), we will share with you our current view on Novavax.
a) The price is inside a descending Wedge, and due to positive news, we are observing a bullish GAP, and we may see the price outside the Wedge pattern
b) The general strategy we will use to develop bullish setups on the pharmaceutical company is waiting for the price to reach 250 - 270 and then an ABC corrective pattern, as you can see on the chart.
c) IF that scenario happens, we will trade above B, and our stop loss will be set below C
d) Regarding the targets, we will be using the Fibo Extensions of the major descending wedge
Thanks for reading!
NVAX Pattern Based Off FractalsSymbol: NASDAQ:NVAX
Top Indicator: Laguerre RSI
Bottom Indicator: Tradingview MACD
Here is a pattern based off of Fractals. We have a divergence in the MACD and two big trendlines coming into play.
We could see a big move either way here, price has been hanging out after a solid move up and the dips are getting bought but we haven't broken out yet.
NVAX aims for $200NVAX COVID vaccines will soon start Stage 3 clinical trial and the expecting result will be very promising.
$NVAX Leaps Calls 480 Jan 21st 2022 or Commons A different kind of COVID-19 vaccine is coming, and it could be 'even more protective'
A COVID-19 vaccine different from those made by Moderna, Johnson & Johnson, and Pfizer could be available to Americans "as soon as this summer," NPR reported on Sunday.
The three vaccines currently authorized for use in the U.S. work by instructing the body to manufacture something that looks like a piece of the virus, but isn't. Then, if ever infected with the real virus, the immune system is prepared. The new protein subunit vaccine, however, already contains that all-important bit, known as the spike protein, meaning the body doesn't have to produce it on its own. What's more, the protein subunit vaccine doesn't require "special refrigeration," and also contains an "adjuvant" that makes the shot "even more protective," per NPR.
The technology itself isn't novel — there are hepatitis B and pertussis vaccines that use the same science. But the first COVID-19 iteration will likely come from biotech company Novavax, which is reportedly hoping to file for authorization in "the U.K., U.S., and Europe in the third quarter," said NPR. Canadian biotech firm Medicago and pharmaceutical giant Sanofi are working to create their own versions, as well. Read more at NPR.
Indicator TutorialSymbol: NASDAQ:NVAX
Indicators
Upper: Delta Volume
On Chart: ALMA x2
Lower: Laguerre RSI
Comments
1. Look at the Large Volume Imbalance and how the price trended after.
2. The widening separation of our Moving Averages.
3. Bottom Indicator Showed Bearish Trend Continuation...
Option Choices
1. Sell Covered Call (Collect Credit)
2. Buy Put (Pay Debit)
3. Sell Call Credit Spread.
4. Buy Put Debit Spread.
NVAX NOT WORTH $5The vax includes SM 102 a toxic flammable liquid causes cancer, toxicity to organs, and skin issues. Doesn’t make income and has no products that are profitable. Worth no more than $5.
Revised PTBased on the long term trend being breached and overall pressures in the market, i expect it to drop further to $75 in coming weeks. I would expect some consolidation in the current area for next few days before a further downtrend resumes.
Symmetrical TriangleSymmetrical Trangles can break either way. A period of consolidation and is considered a neutral pattern. Triangles can also be continuation patterns. NVAX has broken the upper trendline
Price cam up to form this so touch one is on the upper trendline. The 5th touch can be the charm but not always. This one broke the upper trendline on the 5th touch. Price can be dwelling in a triangle for quite some time. When it pushes to the apex, price is "squeezed" snd as a rule it will finally break one way othe other.
No recommendation
$NVAX Gartley Pattern Watching price reversal zone on $NVAX, we took this long from 206 to 262, lets see if we get a reentry chance, prz zone due to 3 triggers per Gartley Pattern rules
